mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.4 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |